Therapy and Medication for Depression, Anxiety, OCD and Trauma: An honest guide to working through medication fears alongside talk therapy

A guide for clients working through fear or stigma around psychiatric medication while engaged in talk therapy.

Key clinical points

Talk therapy alone is often sufficient for mild to moderate depression, anxiety, OCD, and uncomplicated trauma.

Combined therapy and medication is supported by evidence for severe depression, severe OCD, and complex or treatment-resistant trauma.

Effective psychotherapy produces measurable brain change comparable to medication response.

Medication does not replace psychological work. It reduces biological friction that prevents the work from landing.

Fear of medication is clinical information, not resistance, and can be worked with directly in therapy.

Author: Dr Sarah Fischer, Principal Psychologist, Behavioural Edge Psychology, Melbourne, Victoria.

A familiar question with a more nuanced answer than the culture suggests

Most clients arrive at therapy hoping the work will be enough on its own. Some come having tried medication and found it helpful but stigmatised. Others come having been told by family, by friends, or by earlier clinicians that medication is a last resort, a sign of weakness, or a chemical crutch that will dull who they are. The honest clinical answer is more nuanced than any of these positions.

For mild to moderate depression, anxiety, OCD, and uncomplicated trauma, talk therapy alone often produces full recovery. The evidence base supporting this is substantial. For severe presentations, for treatment-resistant presentations, and for certain specific clinical pictures, medication adds something that psychological intervention on its own cannot. The two approaches are complementary, not competing.

This article walks through what the evidence shows for each condition, addresses the most common fears clients carry about taking medication, and offers a way of thinking about the question that prioritises informed choice over either pole of the cultural conversation.

What the evidence actually shows

Depression

The most comprehensive analysis to date was published in World Psychiatry in 2023 (Cuijpers and colleagues), reviewing 409 randomised controlled trials of cognitive behavioural therapy involving 52,702 patients. It found that CBT as a standalone treatment produced moderate to large effects, was as effective as antidepressant medication in the short term and was significantly more effective at 6 to 12 month follow-up. Combined therapy and medication outperformed medication alone but not therapy alone.

The NICE 2022 guidelines on depression in adults (NG222) and the Australian RANZCP Mood Disorders Clinical Practice Guidelines (MDcpg 2020) both recommend stepped care, with psychological intervention as a first-line option for less severe depression and combined treatment for moderate to severe presentations. For mild to moderate depression, talk therapy alone is often sufficient and produces more durable change than medication alone. For severe depression, depression with melancholic features, depression with psychotic features, or depression that has not responded to a course of therapy, medication becomes more important.

Anxiety disorders

For generalised anxiety, social anxiety, panic disorder, and specific phobias, CBT incorporating exposure and behavioural experiments produces large effect sizes as a standalone intervention. Where anxiety is severe, persistent, comorbid with depression, or interfering with the person’s ability to engage in therapy itself, SSRIs or SNRIs can reduce baseline arousal enough to make psychological work possible. The combination is often more effective than either alone for severe presentations, though the threshold for medication consideration is genuinely higher in anxiety than in conditions like bipolar disorder.

Obsessive-compulsive disorder

For mild to moderate OCD, exposure and response prevention (ERP) as a standalone treatment is recommended as first-line by NICE, the American Psychiatric Association, and international OCD treatment consortia. In severe OCD, a combination of ERP and an SSRI is recommended. SSRIs for OCD require higher doses than for depression and longer trials before efficacy is judged, typically at least 12 weeks at therapeutic dose. The combination of ERP and an SSRI produces better outcomes than either alone for severe presentations, but ERP remains the active ingredient that produces lasting symptom change.

Trauma and PTSD

Trauma-focused CBT, EMDR, and prolonged exposure are recommended as first-line treatments for PTSD by NICE, the International Society for Traumatic Stress Studies, and the Australian Phoenix Australia Centre for Posttraumatic Mental Health. SSRIs have evidence as a second-line treatment when trauma-focused therapy is unavailable, declined, or insufficient. Where trauma is complex, where there is chronic autonomic dysregulation, where sleep is severely disrupted, or where comorbid depression and anxiety are interfering with capacity to engage in trauma-focused work, medication can be a meaningful adjunct.

When talk therapy alone is enough

Several factors point toward talk therapy as a sufficient intervention. The presentation is mild to moderate on standardised measures. The person has not been chronically symptomatic for years. There are protective relationships and a reasonably accommodating environment. Sleep, appetite, and basic biological functioning are not significantly disrupted. The person has the cognitive and emotional capacity to engage in the work between sessions. Suicidality, if present, is at the level of passive ideation without specific plan or intent.

Under these conditions, the three mechanisms that sit at the heart of evidence-based psychotherapy, which are cognitive reframing, emotion recognition before escalation, and behavioural activation against avoidance, can produce genuine remission. The brain changes that follow successful psychotherapy are measurable on neuroimaging and overlap substantially with the brain changes that follow successful medication response (Goldapple and colleagues, 2004, Archives of General Psychiatry; DeRubeis, Siegle and Hollon, 2008, Nature Reviews Neuroscience).

When medication adds something therapy alone cannot

Medication should be on the table when severity is high, when biological symptoms are dominant (persistent insomnia, marked appetite change, profound psychomotor slowing, severe autonomic dysregulation), when symptoms have not responded to an adequate course of evidence-based therapy, when suicidality is active, when the person cannot engage in therapy because cognitive or emotional bandwidth is too constrained, or when the diagnosis itself requires it. In these situations, medication is not replacing the psychological work. It is creating the biological conditions under which the psychological work can happen.

A useful frame

Medication does not cause you to function. It removes obstacles. The SSRI does not make you go for a walk, attend therapy, or repair a relationship. It reduces the biological friction against doing those things. The psychological work then does the actual change.

Why fear and stigma about medication develop

Concerns about psychiatric medication are not irrational. They have specific sources worth naming honestly.

Historical context matters. Psychiatric medication has a complicated public history, including periods of overprescription, underprescription, withdrawal effects that were minimised by manufacturers, and population-level marketing campaigns that overstated benefit. Clients are not being paranoid when they ask careful questions about what they are being asked to take.

Cultural narratives shape the conversation. Many clients have grown up in families or communities where mental illness was framed as a weakness, where medication was framed as failure to cope, or where psychological distress was treated as a spiritual or moral problem rather than a medical one. The pressure to manage things naturally can be intense, and that pressure carries its own weight even when the person consciously disagrees with it.

Identity concerns are common. Clients frequently worry that medication will change who they are, dull their creativity, flatten their emotional range, or interfere with their relationships. For some clients, this concern is heightened by previous bad experiences with poorly matched medications or inadequately monitored prescriptions.

Dependency fears are sometimes accurate and sometimes inherited from a previous era. Modern SSRIs and SNRIs are not addictive in the colloquial sense of cravings and tolerance, but they do produce physiological adaptation, and stopping them too quickly can produce discontinuation symptoms. This is a real phenomenon and should not be denied. It is also manageable with proper tapering supervised by your prescribing doctor.

Side effect concerns are often founded on initial-weeks experience rather than steady-state experience. Most antidepressants and many anxiolytics produce more side effects in the first two to four weeks than they do once the body has adapted. Decisions made entirely based on the first fortnight may not reflect what the medication actually does in the longer term.

Working through medication fears with your psychologist

Several principles help in this work.

Treat the fear as information, not as resistance. Fear of medication is data about your history, your beliefs, your values, and your previous experience of being prescribed things. It is worth understanding, not overriding.

Distinguish between fear of medication itself and fear of what taking medication means. For many clients, the more painful question is not whether the drug will work but what it says about them if they need it. That second question is a psychological question, and it sits inside the territory of talk therapy. We can work on it together.

Get specific. Vague worries are harder to address than specific ones. Identify the precise concern. Is it dependency, side effects, withdrawal, loss of self, family judgment, fear of being labelled, cost, or something else entirely. Each concern has its own evidence base and its own appropriate response.

Collaborate with your GP or psychiatrist rather than working in parallel. Your psychologist cannot prescribe but can communicate with the prescribing doctor, with your written consent, to coordinate care, monitor response, and flag concerns. This is standard practice and usually improves outcomes.

Notice the difference between informed consent and inherited belief. Some medication concerns are based on the specific clinical question in front of you. Others are inherited from previous generations, cultural contexts, or earlier experiences that may not apply to your current situation. Sorting one from the other is part of the therapeutic work.

Is it all brain chemistry, or is it all habits?

Neither framing captures what is actually happening. Effective psychotherapy changes brain chemistry. Sustained behavioural and cognitive change reshapes the same neural circuits that medication targets, sometimes more durably. So, talk therapy is not really just talk. It is biologically active work that produces measurable change in the same brain you would otherwise be medicating.

The other side of this is also true. Medication does not cause you to function in the absence of effort. It reduces the biological friction against doing the things that lead to recovery. The two interventions work through related neural pathways and often complement each other. The dichotomy between brain chemistry and habits is a false one. Habits change brain chemistry, and brain chemistry shapes which habits are accessible. Both interventions reach the same circuitry from different directions.

A practical decision framework

For depression, anxiety, OCD, or trauma at mild to moderate severity, talk therapy is a reasonable first-line trial. Reassess at six to eight weeks of consistent engagement. If symptoms are reducing meaningfully, continue. If they are not, the question of whether medication might create the conditions for the work to progress becomes worth opening.

For severe presentations, or for diagnoses where medication is part of standard care, the conversation about medication should happen earlier, ideally at intake. Delaying medication in a severe presentation in service of trying therapy first can extend suffering unnecessarily.

For clients with significant fears about medication, the work of understanding and reducing those fears is itself part of the therapy. It does not have to be resolved before medication is considered, but it should be acknowledged and held alongside the clinical decision rather than dismissed or pushed past.

How we work at Behavioural Edge Psychology

Our practice prioritises informed, collaborative decision-making. We work with clients, their GPs, and where relevant their psychiatrists to coordinate care across psychological and pharmacological interventions. We do not push medication, and we do not push against it. We support clients in making the decision that fits their clinical picture, their values, and their treatment goals.

If you are working with a Behavioural Edge psychologist and considering medication, you can ask us to communicate with your GP about your presentation, what we are working on therapeutically, and what we are observing about your response. With your written consent, we will provide a clinical summary that helps your prescribing doctor make an informed decision alongside the psychological work. This integrated approach usually produces better outcomes than either intervention pursued in isolation.

Frequently asked questions

Does taking medication mean my therapy is not working?

No. The evidence is consistent that for moderate to severe depression, OCD, and PTSD, combined treatment produces better outcomes than either intervention alone. Adding medication is not a failure of therapy. It is a recognition that the biological floor needs to come up before the psychological work can land. Many clients find that medication makes their therapy more effective rather than replacing it.

Will medication change my personality?

Most clients on appropriately matched and dosed medication report feeling more like themselves, not less. The version of you that is depressed, severely anxious, or trauma-activated is not your baseline personality. It is your nervous system under sustained dysregulation. Medication that works well usually quiets the dysregulation enough that your actual personality becomes more available again. If medication is making you feel emotionally flat or unlike yourself, that is clinical information worth bringing back to your prescriber and your psychologist.

How long will I need to take medication?

This depends on the condition, the severity, and the response. For a first episode of depression, current Australian and international guidelines suggest continuing for at least six to nine months after remission, then reassessing. For OCD, continuation is often longer because relapse risk is higher on early discontinuation. For trauma, medication may be used during the active therapy phase and tapered afterwards. Your GP or psychiatrist makes these decisions in consultation with you, ideally with input from your psychologist about how the therapy work is progressing.

Can I stop medication once I feel better?

You should not stop psychiatric medication suddenly. Stopping any psychiatric medication should happen gradually, under medical supervision, ideally at a stable point in your life rather than during an acute stressor. Your prescribing doctor is the right person to plan this with you. Stopping too quickly can produce discontinuation symptoms and increase relapse risk.

What if I do not want to take medication at all?

That is your right and your decision. Your psychologist will respect it. The work will then focus on maximising what psychological intervention can achieve, on monitoring whether the clinical picture is moving in the direction it should be, and on supporting buffering structures around you (sleep, movement, relationships, environment, meaningful activity). If at some point the psychological work is not producing the change you need, the question of medication can be revisited without judgment.

What if my family disapproves of medication?

Family disapproval is a real social pressure and worth taking seriously, but it does not have to determine your treatment decision. Your psychologist can help you think through whether your family’s view reflects a genuine consideration relevant to your situation, an inherited belief from a previous generation, or a projection of their own fears. The decision about your treatment is ultimately yours, and you do not need to disclose it to family members who would not respond supportively.

Working with us

Behavioural Edge Psychology offers consulting rooms in Caulfield South and St Kilda. We work with adults across depression, anxiety, OCD, trauma, neurodivergence assessment, organisational psychology, and medicolegal contexts. If you are considering whether medication might support the therapy work, or working through fears about it, this is a conversation we have often and welcome. You can book through our Cliniko link or contact the practice directly.

References

• Cuijpers et al., 2023, World Psychiatry: verified, DOI 10.1002/wps.21069.

• NICE NG222 (Depression in adults: treatment and management, 2022)

• RANZCP Mood Disorders Clinical Practice Guidelines (MDcpg 2020)

• Goldapple et al., 2004, Archives of General Psychiatry

• DeRubeis, Siegle and Hollon, 2008, Nature Reviews Neuroscience

• Phoenix Australia and ISTSS PTSD guidelines

About the author

Dr Sarah Fischer is the Principal Psychologist of Behavioural Edge Psychology Pty Ltd, with consulting rooms in Caulfield South and St Kilda, Victoria. She holds a PhD in Psychology and a Master of Psychology and is AHPRA-endorsed in organisational psychology. She leads reflective practice and debriefing the Victorian legal sector to reduce impact of vicarious and direct trauma exposure at work. Her practice spans adult neurodivergence assessments using MIGDAS-2 and DIVA-5 protocols, clinical therapy for trauma and complex presentations, WorkSafe Victoria and Transport Accident Commission treating provider work, NDIS-registered services, and medicolegal independent medical examinations. Her therapeutic philosophy is trauma-informed, neurodiversity-affirming, and evidence-based.